News

Investor's Business Daily on MSN8h
Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill
Eli Lilly stock jetted higher Thursday after the company said its diabetes and weight-loss pill helped patients lose up to 16 pounds.
CORXEL Receives Study May Proceed Letter from the U.S. FDA for the Phase 2 Trial of CX11 in Patients with Obesity and Overweight Conditions
The U.S. Phase 2 trial aims to evaluate efficacy and safety of CX11 in doses up to 200 mg and different titration schemesThe ...
Clinical Trials Arena13d
AD/PD 2025: Spotlight on ARIA as new data and evidence emerges for Alzheimer’s DMT use
A key theme at the AD/PD 2025 has been the safety profile of DMTs, focusing on the issue of ARIA, a significant side effect ...
Medscape15d
Cenobamate May Cut Seizures in Drug-Resistant Epilepsy
A real-world study supports cenobamate as an effective option for patients with drug-resistant epilepsy even after multiple ...
Investing.com India3d
Structure Therapeutics shares rise on Pfizer’s obesity drug exit
Shares of Structure Therapeutics Inc ADR (NASDAQ: GPCR) climbed 6.8% following the news that Pfizer Inc. (NYSE: NYSE:PFE) has ...